MyFinsight
Home
Compare
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
|
Compare
Income Overview
Revenue
$13,658K
Net Income
-$24,615K
Net Profit Margin
-180.22%
EPS
-$2.47
Unit: Thousand (K) dollars
Revenue Breakdown
Amount of pharmaceutical revenue...
Amount of digital asset revenue ...
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-12-31
Revenues
13,658
7,274
8,919*
Cost of sales
12,040
4,128
8,507*
Gross profit
1,618
3,146
412*
The amount represents gain (loss) from changes in fair value of digital assets
-21,764
-60,742
-35,748*
Consulting and management fees
1,051
965
1,310*
Professional fees
1,022
653
651*
Share based compensation
1,605
2,771
302*
General and administrative
-
-
348*
Travel expenses
-
-
69*
Represent the amount of bad debt expense
-
-
81*
Operating lease expense
-
-
38*
Depreciation, depletion and amortization, nonproduction
-
-
6*
Other asset impairment charges
-
-
12*
Asset impairment
0
0
-
Other expenses, net
-410
-668
-512*
Operating expenses
25,852
65,799
39,074*
Operating loss
-24,234
-62,653
-38,662*
Interest expense
-89
-66
-50*
Foreign exchange loss (gain)
-34
-23
10*
Gain on disposal of insolvent entities
0
0
280*
Changes in financial instruments at fair value
0
26,073
9,585*
Net loss before income taxes
-24,357
-36,669
-28,837*
Income tax expense
258
-9
15*
Net (loss) income from continuing operations
-24,615
-36,660
-28,852*
Loss from discontinued operations
0
0
-1,080*
Net loss
-24,615
-36,660
-29,933*
Derecognition of equity related to insolvent entities, net of income taxes of nil (nil in 2024)
-
-
149*
It represents the derecognition of equity related to discontinued operations net of income
-
-
-122*
Foreign currency translation, net of income taxes of nil (nil in 2024)
-
-
127*
Net income and comprehensive loss
-
-
-29,833
Basic EPS
-2.47
-3.68
-10,836.451
Diluted EPS
-2.47
-3.68
-10,836.451
Basic Average Shares
9,961
9,958
2,753
Diluted Average Shares
9,961
9,958
2,753
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Net loss
-$24,615K
Net (loss) income
from continuing...
-$24,615K
Amount of
pharmaceutical revenue...
$12,640K
Amount of digital asset
revenue recognized
$1,018K
Net loss before
income taxes
-$24,357K
Income tax expense
$258K
Revenues
$13,658K
Operating loss
-$24,234K
Interest expense
-$89K
Foreign exchange loss
(gain)
-$34K
Gross profit
$1,618K
Cost of sales
$12,040K
Operating expenses
$25,852K
The amount
represents gain (loss) from...
-$21,764K
Share based
compensation
$1,605K
Consulting and management
fees
$1,051K
Professional fees
$1,022K
Other expenses, net
-$410K
Buy us a coffee
ZeroStack Corp. (ZSTK)
ZeroStack Corp. (ZSTK)